MSN: Learn More About Neurofibromatosis: Symptoms, Causes, and Risk Factors for NF1 and NF2 Learn More About Neurofibromatosis: Symptoms, Causes, and Risk Factors for NF1 and NF2 Neurofibromatosis type 2 (NF2) is much less common than NF1, affecting about 1 in 25,000 people worldwide regardless of sex or ethnicity. The disorder is characterized by the development of benign ... Kaleido Scope: Genetic Testing and Genetic Counseling for Neurofibromatosis Type 2 (NF2) Neurofibromatosis type 2 is most often diagnosed based on the presence of physical symptoms that are part of the specific diagnostic criteria for the disorder.

Context Explanation

Genetic testing for the NF2 mutation is ... In a systematic review of death certificates, the mean age of death for individuals with NF1 was 54.4 years (versus 70.1 years in the general population) with death from malignancy disproportionately ... Targeted Oncology: FDA Grants Fast Track Designation to PAS-004 for NF1-Associated Plexiform Neurofibromas The FDA granted fast track designation to PAS-004, a macrocyclic MEK inhibitor, for NF1-associated plexiform neurofibromas causing significant morbidity.